British soldiers are “guinea pigs” for new use of blood clotting agentBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7569.618-a (Published 21 September 2006) Cite this as: BMJ 2006;333:618
- Owen Dyer
British soldiers in Iraq are being treated for traumatic injury with an unlicensed blood clotting agent that has yet to complete clinical trials.
The drug, NovoSeven, also called recombinant factor VIIa, has been licensed for the treatment of haemophilia since 1999 but is still undergoing phase III trials as treatment for traumatic bleeding. It was first used in a military setting four years ago, on a wounded Israeli soldier, and has since been used by US forces in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial